Malaysia moves forward to combat Hepatitis C; issuing compulsory license to produce generic treatment

The Malaysian Cabinet has approved government-use licences to bring in generics of Sofosbuvir – Hepatitis C treatment – amidst Gilead’s current licensing deal. This is in line with the efforts to present more affordable treatment options in the country.
Treating diseases with electrical impulses: A possible alternative in the near future?

Nerve stimulation via controlled electrical impulses while strong in theory have had limited practical implementations in the medical field. That is, until now. Invigorated by multi-million dollar investments, electroceuticals have now been shocked to life — and could serve as an alternative for the future medical treatment.